{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:13:24Z","timestamp":1793294004276,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T00:00:00Z","timestamp":1346198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10875-012-9767-z","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T05:40:29Z","timestamp":1346132429000},"page":"162-171","source":"Crossref","is-referenced-by-count":40,"title":["Mutations of Complement Factor I and Potential Mechanisms of Neuroinflammation in Acute Hemorrhagic Leukoencephalitis"],"prefix":"10.1007","volume":"33","author":[{"given":"Lori","family":"Broderick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhavi","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoon","family":"Shayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Giclas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema S.","family":"Aceves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O.","family":"Newbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,29]]},"reference":[{"key":"9767_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0883073807299971","volume":"22","author":"ET Payne","year":"2007","unstructured":"Payne ET, Rutka JT, Ho TK, Halliday WC, Banwell BL. Treatment leading to dramatic recovery in acute hemorrhagic leukoencephalitis. J Child Neurol. 2007;22:109\u201313.","journal-title":"J Child Neurol"},{"key":"9767_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/338718","volume":"34","author":"JA Leake","year":"2002","unstructured":"Leake JA, Billman GF, Nespeca MP, Duthie SE, Dory CE, Meltzer HS, et al. Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review. Clin Infect Dis. 2002;34:699\u2013703.","journal-title":"Clin Infect Dis"},{"key":"9767_CR3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/00003246-200004000-00037","volume":"28","author":"B Peterson","year":"2000","unstructured":"Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med. 2000;28:1136\u201343.","journal-title":"Crit Care Med"},{"key":"9767_CR4","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.molimm.2008.02.008","volume":"45","author":"IM Ponce-Castro","year":"2008","unstructured":"Ponce-Castro IM, Gonzalez-Rubio C, Delgado-Cervino EM, Abarrategui-Garrido C, Fontan G, Sanchez-Corral P, et al. Molecular characterization of Complement Factor I deficiency in two Spanish families. Mol Immunol. 2008;45:2764\u201371.","journal-title":"Mol Immunol"},{"key":"9767_CR5","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","volume":"44","author":"SC Nilsson","year":"2007","unstructured":"Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol. 2007;44:1835\u201344.","journal-title":"Mol Immunol"},{"key":"9767_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/eji.200838702","volume":"39","author":"SC Nilsson","year":"2009","unstructured":"Nilsson SC, Trouw LA, Renault N, Miteva MA, Genel F, Zelazko M, et al. Genetic, molecular and functional analyses of complement factor I deficiency. Eur J Immunol. 2009;39:310\u201323.","journal-title":"Eur J Immunol"},{"key":"9767_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2003.09.010","volume":"15","author":"GG Kovacs","year":"2004","unstructured":"Kovacs GG, Gasque P, Strobel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, et al. Complement activation in human prion disease. Neurobiol Dis. 2004;15:21\u20138.","journal-title":"Neurobiol Dis"},{"key":"9767_CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1440-1797.2005.00396.x","volume":"10","author":"AR Chowdhury","year":"2005","unstructured":"Chowdhury AR, Ehara T, Higuchi M, Hora K, Shigematsu H. Immunohistochemical detection of immunoglobulins and complements in formaldehyde-fixed and paraffin-embedded renal biopsy tissues; an adjunct for diagnosis of glomerulonephritis. Nephrology (Carlton). 2005;10:298\u2013304.","journal-title":"Nephrology (Carlton)"},{"key":"9767_CR9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.micinf.2008.09.011","volume":"10","author":"G Rambach","year":"2008","unstructured":"Rambach G, Maier H, Vago G, Mohsenipour I, Lass-Florl C, Defant A, et al. Complement induction and complement evasion in patients with cerebral aspergillosis. Microbes Infect. 2008;10:1567\u201376.","journal-title":"Microbes Infect"},{"key":"9767_CR10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779\u201385.","journal-title":"Lancet"},{"key":"9767_CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355:581\u201392.","journal-title":"N Engl J Med"},{"key":"9767_CR12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","volume":"48","author":"SC Nilsson","year":"2011","unstructured":"Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM. Complement factor I in health and disease. Mol Immunol. 2011;48:1611\u201320.","journal-title":"Mol Immunol"},{"key":"9767_CR13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/eji.200939280","volume":"40","author":"SC Nilsson","year":"2010","unstructured":"Nilsson SC, Kalchishkova N, Trouw LA, Fremeaux-Bacchi V, Villoutreix BO, Blom AM. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I. Eur J Immunol. 2010;40:172\u201385.","journal-title":"Eur J Immunol"},{"key":"9767_CR14","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat. 2010;31:E1445\u201360.","journal-title":"Hum Mutat"},{"key":"9767_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","volume":"45","author":"D Kavanagh","year":"2008","unstructured":"Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol. 2008;45:95\u2013105.","journal-title":"Mol Immunol"},{"key":"9767_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","volume":"77","author":"F Bienaime","year":"2010","unstructured":"Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, et al. Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int. 2010;77:339\u201349.","journal-title":"Kidney Int"},{"key":"9767_CR17","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1073\/pnas.1102167108","volume":"108","author":"P Roversi","year":"2011","unstructured":"Roversi P, Johnson S, Caesar JJ, McLean F, Leath KJ, Tsiftsoglou SA, et al. Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A. 2011;108:12839\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9767_CR18","first-page":"131","volume":"74","author":"J Moller Rasmussen","year":"1988","unstructured":"Moller Rasmussen J, Teisner B, Jepsen HH, Svehag SE, Knudsen F, Kirstein H, et al. Three cases of factor I deficiency: the effect of treatment with plasma. Clin Exp Immunol. 1988;74:131\u20136.","journal-title":"Clin Exp Immunol"},{"key":"9767_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clim.2000.4878","volume":"96","author":"GM Naked","year":"2000","unstructured":"Naked GM, Florido MP, Ferreira de Paula P, Vinet AM, Inostroza JS, Isaac L. Deficiency of human complement factor I associated with lowered factor H. Clin Immunol. 2000;96:162\u20137.","journal-title":"Clin Immunol"},{"key":"9767_CR20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/intimm\/12.7.1015","volume":"12","author":"A Thomas","year":"2000","unstructured":"Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M. Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol. 2000;12:1015\u201323.","journal-title":"Int Immunol"},{"key":"9767_CR21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1196\/annals.1352.032","volume":"1056","author":"JP Atkinson","year":"2005","unstructured":"Atkinson JP, Liszewski MK, Richards A, Kavanagh D, Moulton EA. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue. Ann N Y Acad Sci. 2005;1056:144\u201352.","journal-title":"Ann N Y Acad Sci"},{"key":"9767_CR22","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102:7227\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9767_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006252","volume":"5","author":"K Francis","year":"2003","unstructured":"Francis K, van Beek J, Canova C, Neal JW, Gasque P. Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med. 2003;5:1\u201319.","journal-title":"Expert Rev Mol Med"},{"key":"9767_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2003.tb03138.x","volume":"992","author":"J Beek van","year":"2003","unstructured":"van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci. 2003;992:56\u201371.","journal-title":"Ann N Y Acad Sci"},{"key":"9767_CR25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1471-4159.1984.tb12706.x","volume":"42","author":"BA Silverman","year":"1984","unstructured":"Silverman BA, Carney DF, Johnston CA, Vanguri P, Shin ML. Isolation of membrane attack complex of complement from myelin membranes treated with serum complement. J Neurochem. 1984;42:1024\u20139.","journal-title":"J Neurochem"},{"key":"9767_CR26","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1073\/pnas.79.10.3290","volume":"79","author":"P Vanguri","year":"1982","unstructured":"Vanguri P, Koski CL, Silverman B, Shin ML. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc Natl Acad Sci U S A. 1982;79:3290\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9767_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","volume":"49","author":"P Gasque","year":"2000","unstructured":"Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology. 2000;49:171\u201386.","journal-title":"Immunopharmacology"},{"key":"9767_CR28","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.4049\/jimmunol.0800205","volume":"182","author":"MR Griffiths","year":"2009","unstructured":"Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol. 2009;182:4368\u201377.","journal-title":"J Immunol"},{"key":"9767_CR29","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/archneur.58.11.1923","volume":"58","author":"C Gonzalez-Rubio","year":"2001","unstructured":"Gonzalez-Rubio C, Ferreira-Cerdan A, Ponce IM, Arpa J, Fontan G, Lopez-Trascasa M. Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation. Arch Neurol. 2001;58:1923\u20138.","journal-title":"Arch Neurol"},{"key":"9767_CR30","first-page":"385","volume":"87","author":"TJ Vyse","year":"1994","unstructured":"Vyse TJ, Spath PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, et al. Hereditary complement factor I deficiency. QJM. 1994;87:385\u2013401.","journal-title":"QJM"},{"key":"9767_CR31","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720\u201332.","journal-title":"Blood"},{"key":"9767_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jnr.20266","volume":"78","author":"A Basu","year":"2004","unstructured":"Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004;78:151\u20136.","journal-title":"J Neurosci Res"},{"key":"9767_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00060-7","volume":"537","author":"AC Jauneau","year":"2003","unstructured":"Jauneau AC, Ischenko A, Chan P, Fontaine M. Complement component anaphylatoxins upregulate chemokine expression by human astrocytes. FEBS Lett. 2003;537:17\u201322.","journal-title":"FEBS Lett"},{"key":"9767_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2003.12.005","volume":"149","author":"K Palin","year":"2004","unstructured":"Palin K, Verrier D, Tridon V, Hurst J, Perry VH, Dantzer R, et al. Influence of the course of brain inflammation on the endogenous IL-1beta\/IL-1Ra balance in the model of brain delayed-type hypersensitivity response to bacillus Calmette-Guerin in Lewis rats. J Neuroimmunol. 2004;149:22\u201330.","journal-title":"J Neuroimmunol"},{"key":"9767_CR35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","volume":"5","author":"SM Allan","year":"2005","unstructured":"Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5:629\u201340.","journal-title":"Nat Rev Immunol"},{"key":"9767_CR36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(98)00020-4","volume":"85","author":"V Badovinac","year":"1998","unstructured":"Badovinac V, Mostarica-Stojkovic M, Dinarello CA, Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J Neuroimmunol. 1998;85:87\u201395.","journal-title":"J Neuroimmunol"},{"key":"9767_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(95)11923-K","volume":"197","author":"SR Barnum","year":"1995","unstructured":"Barnum SR, Jones JL. Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett. 1995;197:121\u20134.","journal-title":"Neurosci Lett"},{"key":"9767_CR38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000234216","volume":"82","author":"GM Hansch","year":"1987","unstructured":"Hansch GM, Seitz M, Betz M. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol. 1987;82:317\u201320.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"9767_CR39","first-page":"1164","volume":"5","author":"MC Holland","year":"2004","unstructured":"Holland MC, Morikis D, Lambris JD. Synthetic small-molecule complement inhibitors. Curr Opin Investig Drugs. 2004;5:1164\u201373.","journal-title":"Curr Opin Investig Drugs"},{"key":"9767_CR40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"9767_CR41","volume-title":"The PyMOL molecular graphics system","author":"W DeLano","year":"2002","unstructured":"DeLano W. The PyMOL molecular graphics system. San Carlos: DeLano Scientific; 2002."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9767-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9767-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9767-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:14:52Z","timestamp":1559261692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9767-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,29]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["9767"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9767-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,29]]}}}